ApiJect Systems Corporation is an American company founded in 2018 by Marc Koska[2] and based in Stamford, Connecticut[3] that produces pre-filled single use plastic injectors.

[12][10] In November 2020, ApiJect was approved for a $590 million loan from the U.S. International Development Finance Corporation to construct a multi-facility campus.

[17] The CEO of the company stated in July 2020: "The fact of this matter is, it would be crazy for people to just rely on us...We should be America’s backup at this point, but probably not its primary.”[18] According to the White House 100 Days report of June 2021, Health and Human Services is planning to expand Project Jumpstart to $250 million per month through 2023.

[23][24] ApiJect’s prefilled injector uses Blow-Fill-Seal (BFS) manufacturing technology,[15] which is recognized as an advanced aseptic liquid packaging process.

[25] BFS process uses pharmaceutical-grade plastic resin to create, fill and seal a strip of 12-to-25 drug containers per production line every three seconds.